BH3 mimetics reduce adhesion and migration of hepatoblastoma and hepatocellular carcinoma cells

Experimental Cell Research

Volumn 319, Issue 10, 2013, Pages 1443-1450

  Vogt, Fabian ^a   Lieber, Justus ^a   Dewerth, Alexander ^a   Hoh, Alexander ^a   Fuchs, Jörg ^a   Armeanu Ebinger, Sorin ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Adhesion; BH3 mimetics; Cdc42; Hepatoblastoma; Migration; Rho GTPases

Indexed keywords

4 [4 (4' CHLORO 2 BIPHENYLYLMETHYL) 1 PIPERAZINYL] N [4 [3 DIMETHYLAMINO 1 (PHENYLTHIOMETHYL)PROPYLAMINO] 3 NITROBENZENESULFONYL]BENZAMIDE; BH3 PROTEIN; CASPASE 3; CASPASE 7; F ACTIN; GUANOSINE TRIPHOSPHATASE; MATRIGEL; OBATOCLAX; PROTEIN CDC42; RHO GUANINE NUCLEOTIDE BINDING PROTEIN;

ARTICLE; CANCER CELL CULTURE; CELL ADHESION; CELL MIGRATION; CELL MOTILITY; CONTROLLED STUDY; ENZYME ACTIVATION; HEPATOBLASTOMA; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; LIVER CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; WESTERN BLOTTING;

EID: 84877927371     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2013.01.024     Document Type: Article

References (41)

1. Ishak K.G., Gunz P.R. Hepatoblastoma and hepatocarcinoma in infancy and childhood. Report of 47 cases. Cancer 1967, 20.
2. Czauderna P., et al. Surgical treatment of hepatoblastoma in children. Pediatr. Radiol. 2006, 36(3):187-191.
3. Perilongo G., et al. Cisplatin versus cisplatin plus doxorubicin for standard-risk hepatoblastoma. N. Engl. J. Med. 2009, 361(17):1662-1670.
4. Pritchard J., et al. Cisplatin, doxorubicin, and delayed surgery for childhood hepatoblastoma: a successful approach - results of the first prospective study of the International Society of Pediatric Oncology. J. Clin. Oncol. 2000, 18(22):3819-3828.
5. Feusner J.H., et al. Treatment of pulmonary metastases of initial stage I hepatoblastoma in childhood. Report from the Childrens Cancer Group. Cancer 1993, 71(3):859-864.
6. von Schweinitz D., et al. Complete resection before development of drug resistance is essential for survival from advanced hepatoblastoma - a report from the German Cooperative Pediatric Liver Tumor Study HB-89. J. Pediatr. Surg. 1995, 30(6):845-852.
7. Johnstone R.W., Ruefli A.A., Lowe S.W. Apoptosis: a link between cancer genetics and chemotherapy. Cell 2002, 108(2):153-164.
8. Adesina A.M., et al. Gene expression profiling reveals signatures characterizing histologic subtypes of hepatoblastoma and global deregulation in cell growth and survival pathways. Hum. Pathol. 2009, 40(6):843-853.
9. Lieber J., et al. Inhibition of Bcl-2 and Bcl-X enhances chemotherapy sensitivity in hepatoblastoma cells. Pediatr. Blood Cancer 2010, 55(6):1089-1095.
10. Kang M.H., Reynolds C.P. Bcl-2 inhibitors: targeting mitochondrial apoptotic pathways in cancer therapy. Clin. Cancer Res. 2009, 15(4):1126-1132.
11. Chonghaile T.N., Letai A. Mimicking the BH3 domain to kill cancer cells. Oncogene. 27 2008, Suppl 1:S149-S157.
12. Lieber J., et al. The BH3 mimetic ABT-737 increases treatment efficiency of paclitaxel against hepatoblastoma. BMC Cancer 2011, 11(1):362.
13. Oltersdorf T., et al. An inhibitor of Bcl-2 family proteins induces regression of solid tumours. Nature 2005, 435(7042):677-681.
14. Marin J.J., et al. Overview of the molecular bases of resistance to chemotherapy in liver and gastrointestinal tumours. Curr. Mol. Med. 2009, 9(9):1108-1129.
15. Craik A.C., et al. The BH3-only protein Bad confers breast cancer taxane sensitivity through a nonapoptotic mechanism. Oncogene 2010, 29(39):5381-5391.
16. Bangaru M.L., et al. Curcumin (diferuloylmethane) induces apoptosis and blocks migration of human medulloblastoma cells. Anticancer Res. 2010, 30(2):499-504.
17. Grutzmacher C., et al. Opposing effects of bim and bcl-2 on lung endothelial cell migration. Am. J. Physiol. Lung Cell Mol. Physiol. 2010, 299(5):L607-L620.
18. Wang J.F., et al. Expression of Bmi-1 gene in esophageal carcinoma cell EC9706 and its effect on cell cycle, apoptosis and migration. Chin. J. Cancer 2010, 29(7):689-696.
19. Zuo J., et al. Bcl-2 overexpression induces a partial epithelial to mesenchymal transition and promotes squamous carcinoma cell invasion and metastasis. Mol. Cancer Res. 2010, 8(2):170-182.
20. Kayalar C., et al. Cleavage of actin by interleukin 1 beta-converting enzyme to reverse DNase I inhibition. Proc. Natl. Acad. Sci. U. S. A. 1996, 93(5):2234-2238.
21. Takahashi A., et al. Cleavage of lamin A by Mch2 alpha but not CPP32: multiple interleukin 1 beta-converting enzyme-related proteases with distinct substrate recognition properties are active in apoptosis. Proc. Natl. Acad. Sci. U. S. A. 1996, 93(16):8395-8400.
22. Kothakota S., et al. Caspase-3-generated fragment of gelsolin: effector of morphological change in apoptosis. Science 1997, 278(5336):294-298.
23. Beil M., et al. Caspase 8-mediated cleavage of plectin precedes F-actin breakdown in acinar cells during pancreatitis. Am J. Physiol. Gastrointest. Liver Physiol. 2002, 282(3):G450-G460.
24. Sgorbissa A., et al. Caspase-3 and caspase-7 but not caspase-6 cleave Gas2 in vitro: implications for microfilament reorganization during apoptosis. J. Cell Sci. 1999, 112(Pt 23):4475-4482.
25. Tu S., Cerione R.A. Cdc42 is a substrate for caspases and influences Fas-induced apoptosis. J. Biol. Chem. 2001, 276(22):19656-19663.
26. Zhang B., Zhang Y., Shacter E. Caspase 3-mediated inactivation of rac GTPases promotes drug-induced apoptosis in human lymphoma cells. Mol. Cell Biol. 2003, 23(16):5716-5725.
27. Maiuri M.C., et al. BH3-only proteins and BH3 mimetics induce autophagy by competitively disrupting the interaction between Beclin 1 and Bcl-2/Bcl-X(L). Autophagy 2007, 3(4):374-376.
28. McCoy F., et al. Obatoclax induces Atg7-dependent autophagy independent of beclin-1 and BAX/BAK. Cell Death Dis. 2010, 1:e108.
29. Armeanu-Ebinger S., et al. Characterisation of the cell line HC-AFW1 derived from a pediatric hepatocellular carcinoma. PLoS One 2012, 7(5):e38223.
30. Lieber J., et al. Apoptosis sensitizers enhance cytotoxicity in hepatoblastoma cells. Pediatr. Surg. Int. 2012, 28(2):149-159.
31. Koh C.G. Rho GTPases and their regulators in neuronal functions and development. Neurosignals 2006, 15(5):228-237.
32. Sheibani N., et al. Bcl-2 expression modulates cell adhesion and migration promoting branching of ureteric bud cells. J. Cell Physiol. 2007, 210(3):616-625.
33. Cairo S., et al. Hepatic stem-like phenotype and interplay of Wnt/beta-catenin and Myc signaling in aggressive childhood liver cancer. Cancer Cell 2008, 14(6):471-484.
34. Data repository at . http://www.ebi.ac.uk/arrayexpress/experiments/E-MEXP-1851.
35. Zetter B.R. Adhesion molecules in tumor metastasis. Semin. Cancer Biol. 1993, 4(4):219-229.
36. Nobes C.D., Hall A. Rho, rac, and Cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia. Cell 1995, 81(1):53-62.
37. Stengel K., Zheng Y. Cdc42 in oncogenic transformation, invasion, and tumorigenesis. Cell Signal 2011, 23(9):1415-1423.
38. Song J.H., et al. The BH3 mimetic ABT-737 induces cancer cell senescence. Cancer Res. 2011, 71(2):506-515.
39. Bouzahzah B., et al. Rho family GTPases regulate mammary epithelium cell growth and metastasis through distinguishable pathways. Mol. Med. 2001, 7(12):816-830.
40. Johnson E., et al. HER2/ErbB2-induced breast cancer cell migration and invasion require p120 catenin activation of Rac1 and Cdc42. J. Biol. Chem. 2010, 285(38):29491-29501.
41. Gadea G., et al. DOCK10-mediated Cdc42 activation is necessary for amoeboid invasion of melanoma cells. Curr. Biol. 2008, 18(19):1456-1465.